Lucira Health, Inc. Common Stock
LHDX
LHDX was delisted on the 3rd of March, 2023.
44 hedge funds and large institutions have $108M invested in Lucira Health, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 6 increasing their positions, 16 reducing their positions, and 26 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less funds holding
Funds holding: 51 → 44 (-7)
27% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 26
54% less capital invested
Capital invested by funds: $234M → $108M (-$126M)
60% less call options, than puts
Call options by funds: $243K | Put options by funds: $613K
63% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
+$2.52M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$401K |
| 3 |
ECG
EPIQ Capital Group
San Francisco,
California
|
+$377K |
| 4 |
IC
IEQ Capital
Foster City,
California
|
+$291K |
| 5 |
E
Ergoteles
New York
|
+$268K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$13.5M |
| 2 |
JP Morgan Chase
New York
|
-$3.46M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$3.15M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$3.02M |
| 5 |
BlackRock
New York
|
-$2.78M |
LHDX Hedge Fund Activity: Q2 2021 in Review
44 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Lucira Health, Inc. Common Stock (LHDX) for Q2 2021, worth a combined $108M — down 54% from $234M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of LHDX and 19 opened new positions — a net loss of 7 holders — while 16 trimmed existing stakes and 6 added.
The largest buyer was Pura Vida Investments, opening a new position worth an estimated $2.52M. The largest seller was Capital Research Global Investors, exiting entirely with an estimated $13.5M sold.
- 44 institutional investors held Lucira Health, Inc. Common Stock (LHDX) as of Q2 2021, down from 51 in Q1 2021.
- Funds reported $108M of Lucira Health, Inc. Common Stock stock for Q2 2021, down 54% quarter-over-quarter.
- 19 funds opened new Lucira Health, Inc. Common Stock positions in Q2 2021 and 26 closed out, a net change of -7 holders.
- The largest Lucira Health, Inc. Common Stock buyer in Q2 2021 was Pura Vida Investments, an estimated $2.52M added.
- The largest Lucira Health, Inc. Common Stock seller in Q2 2021 was Capital Research Global Investors, an estimated $13.5M sold.
Based on aggregated 13F filings for Q2 2021.